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ab T cell receptors (TCRs) bind specifically to foreign
antigens presented bymajor histocompatibility com-
plex proteins (MHC) or MHC-like molecules. Accu-
mulating evidence indicates that the germline-
encoded TCR segments have features that promote
binding toMHC andMHC-likemolecules, suggesting
coevolution between TCR andMHCmolecules. Here,
we assess directly the evolutionary conservation of
ab TCR specificity for MHC. Sequence comparisons
showed that some Vbs from distantly related jawed
vertebrates share amino acids in their complemen-
tarity determining region 2 (CDR2). Chimeric TCRs
containing amphibian, bony fish, or cartilaginous
fish Vbs can recognize antigens presented by mouse
MHC class II and CD1d (an MHC-like protein), and
this recognition is dependent upon the shared CDR2
amino acids. These results indicate that features of
the TCR that control specificity for MHC and MHC-
like molecules were selected early in evolution and
maintained between species that last shared a com-
mon ancestor more than 400 million years ago.
INTRODUCTION
In jawed vertebrates, foreign antigens are recognized by B cells
and T cells. Both B cells and T cells generate diverse antigen
receptors via random rearrangements of germline-encoded
gene segments. Whereas B cell antigen receptors bind directly
to many types of antigens, T cells bearing ab T cell receptors
(TCRs) recognize antigen bound to major histocompatibility
complex (MHC) or MHC-like molecules on cell surfaces (Hansen
et al., 2007; Hu¨nig and Bevan, 1981; Kappler et al., 1981; Mar-
rack et al., 2008; Rudolph et al., 2006; Zinkernagel and Doherty,
1974). The TCR binding site is composed of the combination of
peptide fragments of antigens and MHCI or MHCII molecules526 Immunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc.(Babbitt et al., 1985; Bjorkman et al., 1987; Townsend et al.,
1985) or of lipids or glycolipids and MHC-like molecules such
as CD1d (Bendelac et al., 1995, 2007; Cui et al., 1997; Silk
et al., 2008).
The fact that ab T cells are constrained by their requirement for
recognition of MHC as well as antigen has long mystified scien-
tists. Certainly, such a requirement ensures that T cells will
always react with other cells, an important attribute. How-
ever, the phenomenon remains poorly understood. This property
of the ab TCR is partly determined during T cell development in
the thymus where thymocytes are allowed to mature only if they
express a TCR that can bind MHC or MHC-like molecules
(Bevan, 1977b; Fink and Bevan, 1978; Kisielow et al., 1988;
Sha et al., 1988; Zinkernagel et al., 1978). Thymic selection
therefore shapes the randomTCR repertoire in favor of receptors
that can recognize self-MHC (Bevan, 1977b; Goldrath and
Bevan, 1999).
However, several observations have suggested that the
specificity of the random, unselected repertoire of TCRs is also
biased in favor of binding MHC (Blackman et al., 1986; Jerne,
1971; Marrack et al., 2008; Merkenschlager et al., 1997; Zerrahn
et al., 1997). For example, at least one in five randomly created
TCRs can recognize MHC (Merkenschlager et al., 1997; Zerrahn
et al., 1997). This idea is supported by structural analyses
of TCR-MHC interactions (Garcia et al., 2009; Marrack et al.,
2008). Although there are exceptions, different mouse and
human TCRs frequently interact with MHC in a similar, diagonal,
orientation, and in the complexes, the angled position places the
germline-encoded CDR1 and CDR2 loops of the TCR Va and Vb
segments over the MHC a helices such that certain CDR1 and
CDR2 amino acids often contribute to, and are important in,
engagement of MHC (Marrack et al., 2008; Rudolph et al., 2006).
Some ab T cells recognize antigens presented by MHC-like
molecules such as those of the CD1 family and MR1 (Bendelac
et al., 1995; Hansen et al., 2007; Silk et al., 2008). Among the
MHC-likemolecules, detailed analysis of the interaction between
the TCR expressed by natural killer T (NKT) cells and glycolipid
antigens presented by CD1d revealed that, by comparison
with TCR interactions with MHC, the NKT TCR is oriented differ-
ently when bound to CD1d. Nevertheless, the TCR recognizes
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Figure 1. Conserved CDR2 Motif Present in Jawed Vertebrate Vb
despite Low Primary Vb Sequence Conservation
(A) Amino acid sequence identity between mouse Vb8.2 and human, mouse,
opossum, frog, and trout Vb regions from pairwise alignments in ClustalW2
with the PAM scoring matrix.
(B) Predicted CDR2 sequences of jawed vertebrate Vb regions containing
amino acids Y46 and Y48. Those that also contain E54 are indicated.
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Conserved Features that Control ab TCR Specificityjointly the complex of antigen and CD1d and certain TCR CDR
amino acids contribute consistently to engagement of CD1d
(Borg et al., 2007; Mallevaey et al., 2009; Pellicci et al., 2009;
Scott-Browne et al., 2007).
These ideas led to the hypothesis that germline-encoded TCR
gene segments might have been selected by evolution to
promote recognition of cell-associated antigens bound to MHC
and MHC-like molecules. TCR and MHC genes are present in
all jawed vertebrates (Flajnik and Kasahara, 2010; Litman et al.,
2010; Rast et al., 1997), and therefore such a hypothesis is
reasonable. However, even if the hypothesis is correct, the
predisposition of TCRs and MHC to interact with each other
may not be conferred by the same amino acids in every species.
Indeed, MHC genes are very polymorphic within species, and
many different TCR-variable gene sequences can be found in
every species examined, suggesting that this might not be the
case. However, careful comparison of jawed vertebrate TCRb
chain variable (Vb) sequences revealed that, despitemany amino
acid differences, a motif shown to dictate the TCR bias for MHC
inmice and humans is also present in some Vbs of these species.
Here we show that these Vbs can contribute to MHC + peptide
and CD1d + glycolipid ligand recognition by TCRs that are other-
wise mouse in origin. These properties depend on the amino
acids of the conserved motif. Thus, features of the TCR that
promote binding to MHC were present early during vertebrate
evolution and have been maintained in several species that last
shared a common ancestor more than 400 million years ago.
RESULTS
A Common Complementarity-Determining Region-2
Motif in Jawed Vertebrate Vbs
To understand how evolutionary pressures may have selected
TCR variable (V) regions toward specificity for MHC, we com-
pared the amino acid sequence ofMusmusculus (house mouse)
Vb8.2 with those of Vb domains from several species of major
jawed vertebrate lineages. Amino acid sequences for Vbs in
mouse, Homo sapiens (human), Xenopus laevis (African clawed
frog), and Oncorhynchus mykiss (rainbow trout) were isolated
from the ImMunoGeneTics information system database
(Lefranc et al., 2009), and the predicted amino acid sequences
of Monodelphis domestica (opossum) Vbs were generated via
translation of genomic DNA sequences (Parra et al., 2008).
When the full-length Vb sequences from these species were
aligned, most Vb domains had less than 30% amino acid identity
with mouse Vb8.2 (Figure 1A). A few human andmouse Vbs were
highly similar to Vb8.2, but none of the frog or trout Vbs were
substantially more similar to mouse Vb8.2 than the average
(Figure 1A).
Because TCR V regions bind MHC via amino acids in their
complementarity-determining region (CDR) loops, we hypothe-
sized that, in order to preserve this function, motifs in these
regions might have been specifically conserved. This idea is
supported by the crystallographic and mutational analyses of
TCRs, which have shown that some germline-encoded TCR
amino acids contribute consistently to binding MHC (Garcia
et al., 2009; Marrack et al., 2008). For example, in eight com-
plexes of TCRs containing mouse Vb8 family members bound
to MHCII, CDR2 amino acids Y46, Y48, and E54 bind MHCII ata common site (see Figure S1A available online; Dai et al.,
2008; Feng et al., 2007; Maynard et al., 2005). For TCR-MHCI
complexes, Vb8 CDR2 amino acids Y46 and Y48 are also posi-
tioned over a similar site on the MHCI a1 a helix, with at least
one of them making direct contact with the MHCI molecules in
all the structures examined (Figure S1B; Buslepp et al., 2003;
Colf et al., 2007; Yin et al., 2011). Furthermore, in one TCR-
MHCI complex, these CDR2 amino acids from a mouse TCR
bind human MHCI HLA-A2, suggesting that this interaction is
shared between the species (Figure S1B; Buslepp et al., 2003).
Thus, these Vb CDR2 amino acids are required for recognition
of antigens presented by MHCI, MHCII, and CD1d (Borg et al.,
2007; Dai et al., 2008; Feng et al., 2007; Manning et al., 1998;
Rubtsova et al., 2009; Scott-Browne et al., 2007, 2009) and
also control MHC-dependent thymic selection of a broad reper-
toire of T cells (Scott-Browne et al., 2009).
We searched for Vb CDR2 amino acids Y46 and Y48 in the
appropriate positions in Vbs from human, mouse, opossum,Immunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc. 527
Table 1. Comparison of Mouse, Frog, Trout, and Shark Vb Region Sequences
Species Common Name Class Vb CDR1 CDR2 Identity (with Vb8.2)
M. musculus house mouse Mammalia Vb8.2 NNHNN YSYGAGSTE -
X. laevis African clawed frog Amphibia TRBV2 DSSKVS YTYTTITIE 27%
O. mykiss rainbow trout Osteichthyes TRBV8S2 DSNLLV YSYGTTEPN 20%
H. francisci horn shark Chondrichthyes Vb3-Hf73 DSSKSV YSYTGSSPT 33%
CDR2 residues predicted to be important for generic interaction with MHC are in bold.
Immunity
Conserved Features that Control ab TCR Specificityfrog, and trout, as well as from Gallus gallus domesticus
(chicken), Anolis carolinensis (Carolina anole lizard), and
Heterodontus francisci (horn shark) (Hawke et al., 1996). Y46
and Y48 were jointly present in four human Vbs, four mouse
Vbs, three opossum Vbs, one chicken Vb, three predicted lizard
Vbs, one frog Vb, four trout Vbs, and three shark Vbs (Figure 1B).
In addition, E54, an amino acid that is found in the mouse Vb8
family and that consistently engages MHC class II (Figure S1A),
was found in combination with Y46 and Y48 in the human
TRBV25, opossum TRBV6, and frog TRVB2 (Figure 1B). These
observations identified a common motif shared between Vbs
from different jawed vertebrate species that last shared a com-
mon ancestor more than 400 million years ago.
Conserved CDR2 Amino Acids Control Frog, Fish,
and Shark Vb Binding to Mouse MHCII
To assess the function of these Vbs, we replaced the mouse
Vb8.2 region of the DO-11.10 TCRb (White et al., 1983) with
frog TRBV2, trout TRBV8S2, or shark Vb3-Hf73 (Table 1 and Fig-
ure S2). Only 30% of the amino acids in the sequence of these
Vbs are shared with mouse Vb8.2, and most identical amino
acids are in regions that stabilize the Vb domain or form the inter-
face with Va (Table 1 and Figure S2A). The amino acids in the
CDR1 loops of frog TRBV2, trout TRBV8S2, and shark Vb3-
Hf73 are similar to each other, but these amino acids are dissim-
ilar with those in mouse Vb8.2 (Table 1 and Figure S2A). AmongA
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528 Immunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc.the amino acids in the CDR2 loop, only Y46 and Y48 are present
in all four Vbs while E54 is present in both mouse Vb8.2 and frog
TRBV2 (Table 1). For the most part, the sequences vary at the
other CDR2 positions, except for the presence of a Ser or Thr
at position 49, which has been observed to be important for
a properly folded protein (Manning et al., 1998; Scott-Browne
et al., 2007). To refer to the DO-11.10 TCRb containing the
different Vbs, we will use the common name of the species of
origin (mouse DOb, frog DOb, trout DOb, and shark DOb).
We independently expressed mouse DOb, frog DOb, trout
DOb, or shark DOb with the full-length mouse TCRb constant
region (Cb) in hybridomas with the mouse DO-11.10 TCRa (Fig-
ure 2A). The cells stained comparably with an antibody specific
for the TCRb constant region, regardless of the source of their
Vb (Figure S3A), suggesting that these various Vb chains were
able to fold and pair properly with the mouse TCRa chain.
We used these cells to assess antigen recognition by TCRs
containing the different TCRb chains. The TCR composed of
the natural DOa plus mouse DOb recognizes mouse MHCII IAd
plus a chicken ovalbumin peptide (IAd-OVA) (White et al.,
1983). Hybridomas expressing DOa with the frog DOb or the
trout DOb also responded to IAd-OVA (Figure 2B), although
high concentrations of OVA peptide were necessary to stimulate
cells bearing the trout DOb. Cells expressing the DOa plus
shark DOb did not respond to any concentration of peptide
(Figure 2B).3 105
nly
3 105
nly
Figure 2. Hybridomas Expressing Mouse DO-11.10 TCRa
Plus DO-11.10 TCRb with Mouse, Frog, Trout, and Shark Vb
Respond to Cells Expressing Mouse MHCII IAd Plus OVA
Peptide
(A) Schematic of chimeric TCRb construction replacing mouse Vb8.2
with frog, trout, and shark Vb in the DO-11.10 TCRb with full-length
mouse TCRb constant region for expression in hybridomas.
(B andC) IL-2 production of 5KC-73.8.20 hybridomas expressingwild-
type DOa (B) or S93A DOa (C) plus mouse DOb, frog DOb, trout DOb,
shark DOb, or no TCRb after stimulation with IAd-expressing A20.2J
cells plus the indicated concentration of OVA323-339 peptide. Filled
circles indicate wild-type TCRb and open circles indicate Y48A TCRb.
Data are mean of two independent experiments, with a lower limit of
detection of IL-2 at 50 pg ml1.
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Figure 3. TCRs Containing Mouse, Frog, Trout, and Shark Vb
Bind Mouse MHCII via Conserved Vb CDR2 Amino Acids
(A) Schematic of chimeric TCRb construction replacing mouse Vb8.2
with frog, trout, and shark Vb in the DO-11.10 TCRb for expression in
insect cells. The mouse TCRb constant region was truncated just
before the transmembrane domain (DTM) and linked to a leucine
zipper and baculovirus gp64 protein transmembrane (TM) domain.
(B) IAb-3K or IAd-OVA tetramer staining and TCRb expression on SF9
insect cells expressing DOaS93A plus mouse DOb, frog DOb, trout
DOb, or shark DOb compared with SF9 cells expressing surface-
bound MHCII IAb plus linked 3K peptide. Plots are gated on live cells
and are representative of at least two independent experiments.
(C) Geometric mean fluorescence intensity (gMFI) of normalized
IAd-OVA tetramer staining on SF9 insect cells expressing DOaS93A
plus wild-type (WT) mouse DOb, frog DOb, trout DOb, or shark DOb
and indicated CDR2b amino acid Ala substitutions. Tetramer staining
was normalized by dividing gMFI of IAd-OVA staining by gMFI of
background IAb-3K staining from a narrow gate of TCR expression.
Data are mean ± range from two independent experiments.
Immunity
Conserved Features that Control ab TCR SpecificityTo determine whether the conserved amino acids in Vb CDR2
were involved in this recognition, we generated hybridomas ex-
pressingmutantsofmouseDOb, frogDOb, and troutDOb inwhich
Y48 was substituted with Ala (Y48A). In all cases, the Y48A sub-
stitution reduced responses to IAd-OVA (Figure 2B), whereas all
hybridomas responded comparably to anti-CD3ε stimulation
(Figure S3B). Thus the evolutionarily conserved Vb Y48 amino
acid is involved in recognition of IAd-OVA in all three cases.
We have previously identified a natural variant of DOa, with
a Ser to Ala (S93A) change in the CDR3 (Scott-Browne et al.,
2009). Hybridomas expressing mouse DOb plus DOaS93A stain
with IAd-OVA tetramer better than do cells expressing DOaWT,
indicating that this CDR3 change increases TCR affinity for
IAd-OVA (Figure S3C). We tested whether the S93A substitution
in DOa would also improve IAd-OVA recognition by TCRs that
contained the various species’ Vbs, and whether it would reveal
a reactivity of shark DOb-containing TCRs for IAd-OVA. This
turned out to be true; hybridomas expressing DOaS93A plus
mouse DOb or frog DOb or trout DOb, or even shark DOb, all re-
sponded to IAd-OVA (Figure 2C). In fact, the hybridoma bearing
DOaS93A plus frog DOb responded to the IAd-expressing cells
even in the absence of OVA peptide (Figure 2C). An IAd-specific
antibody blocked this autoreactivity and the cells did not re-
spond when cultured alone or with H-2k antigen-presenting cells
(Figure S3D). Altogether, these results suggest that the autor-
eactive response of the hybridoma is mediated by a self-peptide
presented by a H-2d MHCII molecule.
We next measured directly the binding of the various TCRs to
IAd-OVA. Because the DO-11.10 TCR is of somewhat low affinityImmufor IAd-OVA, fluorescently labeled IAd-OVA tetramers
stain the T cell hybridomas poorly (Figure S3C). Because
MHC tetramer staining intensity is proportional to the
amount of TCR expressed on the cell surface, we devel-
oped a system to express TCRs at higher concentrations
on the surface of insect cells. In this setting, the TCRa and
TCRb transmembrane domains are replaced by acidic
and basic leucine zippers, respectively (Figure 3A; Kap-
pler et al., 1994), and the transmembrane domain of the
baculoviral gp64 protein is fused to the COOH terminusof the TCRb chain to retain the protein on the insect cell surface
(Figure 3A; Huseby et al., 2006; Stadinski et al., 2010).
With this system, we expressed DOaS93A plus mouse DOb,
frog DOb, trout DOb, or shark DOb on the surface of SF9 cells
with baculoviruses. All TCR pairs were expressed on the cell
surface and stained specifically with IAd-OVA tetramers. No
staining was detected with control IAb-3K or IAd-CLIP tetramers
(Figures 3B and S4A). To assess the contribution of the con-
served Vb CDR2 amino acids to this reactivity, we repeated
the experiment with Ala substitutions of Y46 or Y48 in all of the
Vbs and with Ala substitution of E54 in mouse DOb and frog
DOb. For all TCRs, the Y46A and Y48A changes reduced
IAd-OVA tetramer staining compared to the wild-type TCRb of
the same species (Figures 3C and S4A). The E54A mutation in
mouse DOb impaired the interaction with IAd-OVA, but this
change in frog DOb only slightly reduced staining compared to
wild-type frog DOb (Figures 3C and S4A).
To assess whether these CDR2bmutationsmight have altered
the expression or folding of the TCR, we expressed the TCRb
chains by using retroviruses containing an internal ribosome
entry site linked to green fluorescent protein (IRES-GFP) as
a reporter in T cell hybridomas together with the Va2-containing
B3K0508 TCRa chain (Huseby et al., 2005). Cells expressing
each of the TCRb chains stained similarly with antibodies
specific for the TCRb constant region compared to the expres-
sion of GFP (Figure S4B). Similarly, the staining with a Va2-
specific antibody for the partner TCRa chain was similar for all
TCRb chains, indicating that the mutations did not affect the
overall structure of the TCR (Figure S4B).nity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc. 529
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Figure 4. Thymic Selection of Mouse Cells
Expressing a Frog Vb Containing TCRb Is
Controlled by CDR2 Amino Acid Y48
(A) Schematic of retroviral-mediated expression of
frog DOb in mice via bone marrow chimeras.
(B) Flow cytometry analysis of CD4 and CD8
expression, CD5 and CD69 expression, or CD24
and TCRb expression on thymocytes from mice
expressing WT or Y48A frog DOb. Plots are gated
on live, GFP-positive cells and are representative
of two independent experiments.
(C) Total number of thymocytes inmice expressing
WT or Y48A frog DOb.
(D) Frequency of activated (CD5hiCD69+) or ma-
ture (CD24loTCRbhi) cells among GFP-expressing
thymocytes in chimera expressing WT or Y48A
frog DOb.
(E) Total number of mature CD24loTCRbhi CD4SP
(left) or CD8SP (right) thymocytes from mice ex-
pressing WT or Y48A frog DOb.
(F) Frequency of Va2 and Va8.3 expressing
CD4+ (left) or CD8+ (right) LN T cells from mice
expressing WT frog DOb (white bars) or Y48A frog
DOb (gray bars).
Data in (C)–(F) are mean ± SD and include all mice
from two independent experiments (n = 8 for WT
frog DOb, n = 9 for Y48A frog DOb); ***p < 0.001;
N.S., not significant.
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Conserved Features that Control ab TCR SpecificityAltogether, these observations indicate that TCRs containing
frog, trout, and shark Vb regions can all bind mouse MHCII.
This cross-species interaction occurs despite differences at
70% of the amino acids, including those in the CDR1 loop in
the Vbs compared tomouse Vb8.2 (Table 1). Instead, in all cases,
two conserved amino acids (Y46 and Y48) in CDR2 contribute
substantially to the TCR-MHC interaction.
Frog Vb CDR2 Amino Acid Y48 Controls Thymic
Selection in Mice
We have shown previously that efficient thymic selection of
a diverse repertoire of TCRs in mice depends on the Vb CDR2
amino acids that comprise the MHC-binding motif, particularly
the tyrosine at position 48 (Scott-Browne et al., 2009). To deter-
mine whether frog TRBV2 could promote T cell development in
mice and whether thymic selection in mice was dependent on
the evolutionarily conserved Vb CDR2 amino acid Y48, we
generated mice expressing wild-type frog DOb or Y48A frog
DOb. Bone marrow chimeras were generated with donor cells
transduced with retroviruses expressing the TCRb plus IRES-
GFP as a reporter (Figure 4A).
We observed the characteristic developmental subsets (Fig-
ure 4B) in the thymuses of mice expressing each of the TCRb
chains indicating that a TCR containing a frog Vb can initiate
b and positive selection in mice. Additionally, mice expressing
wild-type or Y48A frog DOb had comparable thymic cellularity
(Figure 4C) with similar GFP expression and TCRb expression
profiles (Figure S5). In mice expressing Y48A frog DOb, the
frequency of immature CD4+CD8+ double-positive thymocytes
was increased, whereas the frequencies of CD4 single-positive
(CD4SP) and CD8 single-positive (CD8SP) thymocytes were
reduced, compared to mice expressing the wild-type frog DOb
(Figure 4C). This reduction in positive selection effected by the
Y48A mutation in the frog Vb was confirmed by the lower530 Immunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc.frequencies of positively selected activated (CD5+CD69+) and
mature (CD24loTCRbhi) thymocytes in chimeras expressing
Y48A frog DOb compared to those expressing wild-type frog
DOb (Figure 4D). As an estimation of thymic output, we calcu-
lated the total numbers of mature CD4SP and CD8SP thymo-
cytes. These were reduced in mice expressing Y48A versus
wild-type frog DOb (Figure 4E), indicating that recognition of
both MHC class II and MHC class I during thymic selection is
impaired by mutation of this CDR2 amino acid.
Although the Y48A substitution in mouse DOb greatly impairs
thymic selection, some T cells bearing the mutant TCRb can
nevertheless be positively selected (Scott-Browne et al., 2009).
These T cells use a different TCRa repertoire than do cells
bearing the wild-type mouse DOb, perhaps because cells ex-
pressing Y48A mouse DOb require a greater contribution of
TCRa to MHC binding (Scott-Browne et al., 2009). We tested
whether the TCRa repertoire was also altered in T cells bearing
Y48A frog DOb versus wild-type frog DOb. The frequency of
CD4+ T cells expressing Va2 or Va8.3 was reduced, by com-
parisonwith wild-type frog DOb, in Y48A frog DOb chimeras (Fig-
ure 4F). Va2-expressing CD8+ T cells were also reduced,
whereas the frequency of Va8.3-expressing CD8+ cells was
increased in Y48A frog DOb chimeras (Figure 4F). Interestingly,
these changes in Va use are similar to results obtained in compa-
rable experiments with variants of mouse DOb (Scott-Browne
et al., 2009).
Conserved CDR2 Amino Acids Are Required for Frog,
Fish, and Shark Vb to Bind Mouse CD1d
Some ab T cells recognize MHC-like molecules, such as the
mammalian CD1 family, which present lipid antigens (Bendelac
et al., 1995; Silk et al., 2008). Genes encoding CD1-like proteins
are present in birds but not in amphibians or bony or cartilagi-
nous fish (Dascher, 2007). CD1d is found only in mammals
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Figure 5. NKT TCRs Containing Mouse, Frog, Trout, and Shark Vb
Bind Mouse CD1d by a Conserved Motif
(A) Flow cytometry analysis of TCRb expression andCD1d tetramer staining on
5KC-73.8.20 hybridomas expressing wild-type Va14-Ja18 NKT TCRa (iNKTa)
plus mouse DOb, frog DOb, trout DOb, or shark DOb.
(B) gMFI of CD1d-PBS57 tetramer staining on 5KC-73.8.20 hybridomas ex-
pressing wild-type iNKTa plus WT mouse DOb, frog DOb, trout DOb, or shark
DOb and indicated CDR2b amino acid Ala substitutions. Data are gMFI ± range
calculated from a narrow gate of TCRb expression from two independent
experiments. The dotted line indicates average MFI of CD1d-PBS57 tetramer
staining on 5KC-73.8.20 hybridomas expressing only the iNKTa and no TCRb.
(C) IL-2 secretion from 5KC-73.8.20 hybridomas expressing iNKTa plus wild-
type (filled circles) or Y48A (open circles) mouse DOb, frog DOb, trout DOb, or
shark DOb after stimulation with A20 cells expressing mouse CD1d plus the
indicated concentration of a-GalCer. Data are mean of two independent
experiments, with a lower limit of detection of IL-2 at 50 pg ml1.
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Conserved Features that Control ab TCR Specificity(Dascher, 2007) and a special ab T cell population, the natural
killer T (NKT) cells, recognizes glycolipid antigens presented by
CD1d (Bendelac et al., 1995, 2007; Cui et al., 1997). In mice,
most NKT cells express a restricted TCR repertoire with an
invariant TCRa (iNKTa) (Lantz and Bendelac, 1994) and a biased
but diverse repertoire of TCRbs that often involve Vb8.2. In fact,
pairing the DO-11.10 TCRb with iNKTa allows reaction with
CD1d plus multiple glycolipids (Scott-Browne et al., 2007).
Although the orientation of the NKT TCR on CD1d differs mark-
edly from that of conventional ab TCRs bound to MHCI and
MHCII, the Vb8.2 CDR2 amino acids Y46, Y48, and E54 also
bind CD1d (Borg et al., 2007; Pellicci et al., 2009) and are
required for antigen recognition (Mallevaey et al., 2009; Scott-
Browne et al., 2007).
To find out whether nonmammalian Vbs could participate in
CD1d binding, we expressed mouse DOb, frog DOb, trout
DOb, or shark DOb (Figure 2A) in hybridomas with the mouse
iNKTa. TCRs containing any of these Vbs stained specifically
with mouse CD1d tetramers loaded with the synthetic glycolipid
antigen PBS57 (Liu et al., 2006) and did not stain with the same
tetramer without addition of antigen (Figure 5A). To determine
whether the Vb CDR2 amino acids Y46, Y48, or E54 were in-
volved in antigen recognition, we used hybridomas expressing
Ala substitutions of Y46 and Y48 in each of the Vbs and Ala
substitutions for E54 in mouse DOb or frog DOb. Y46 and Y48
contributed to CD1d binding for all four TCRs; the Y46A and
Y48A substitutions in mouse DOb and frog DOb and Y48A
substitution in trout DOb and shark DOb completely eliminated
interaction with CD1d-PBS57 tetramers (Figures 5B and S6).
Trout DOb and shark DOb had a slightly different pattern, as
shown by the fact that mutation of Y46 reduced, but did not
completely eliminate, staining with CD1d-PBS57 tetramers (Fig-
ures 5B and S6). Finally, hybridomas expressing iNKTa plus
wild-type mouse, frog, trout, and shark TCRb chains secreted
IL-2 after stimulation with a-galactosylceramide presented by
CD1d-expressing APCs, whereas cells expressing TCRb chains
with the Y48A substitution were unresponsive at all concentra-
tions of antigen (Figure 5C). Thus, a common motif in jawed
vertebrate TCR Vb contributes to recognition of antigens pre-
sented by both MHC and CD1d.
DISCUSSION
The genes encoding TCRa, TCRb, MHCI, MHCII, and MHC-like
molecules have been identified in all lineages of jawed verte-
brates, including the cartilaginous fishes, which last shared
a common ancestor with mammals more than 400 million years
ago (Cooper and Alder, 2006; Flajnik and Kasahara, 2010;
Hawke et al., 1996; Litman et al., 1999, 2010; Rast et al., 1995,
1997). Although the ab T cell recognition of MHC has primarily
been characterized in mammals, evidence for MHC-dependent
T cell immunity has been observed in other vertebrate lineages
as well (Litman et al., 1999).
These observations led us to investigate the features that
control the specificity of ab TCRs for MHC. Based on the many
functional, mutational, and crystallographic analyses, we and
others have observed that germline-encoded features of some
mammalian ab TCR V regions promote recognition of MHC
and MHC-like molecules (Borg et al., 2007; Dai et al., 2008;Feng et al., 2007; Jerne, 1971; Lee et al., 2000; Mallevaey
et al., 2009; Manning et al., 1998; Marrack et al., 2008; Maynard
et al., 2005; Newell et al., 2011; Rudolph et al., 2006; Scott-
Browne et al., 2007, 2009; Sim et al., 1996). This leads directly
to the hypothesis that evolutionary pressures have selected
these regions for interaction with MHC (Jerne, 1971; Marrack
et al., 2008), thereby promoting T cell recognition of cell-associ-
ated antigens.
We and others have previously identified a motif in the CDR2
loop of somemouse and human Vbs. Structural and biochemical
studies have shown that the amino acids that define this motif
are consistently involved in engagement of MHCI, MHCII, andImmunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc. 531
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Conserved Features that Control ab TCR Specificitythe MHC-like protein CD1d (Borg et al., 2007; Dai et al., 2008;
Feng et al., 2007; Jerne, 1971; Lee et al., 2000; Manning et al.,
1998; Marrack et al., 2008; Maynard et al., 2005; Rudolph
et al., 2006; Scott-Browne et al., 2007, 2009). We found that
this Vb CDR2 motif was also present in some Vbs from jawed
vertebrate species distantly related to mammals. Even though
the overall sequence of these Vbs was only 30% similar to those
of mouse and human, these distant species’ Vbs could neverthe-
less substitute for themouse Vb in recognition of mouseMHCII +
peptide. More amazingly, the Vbs from the distant species could
substitute for mouse Vb in recognition of mouse CD1d + glyco-
lipid, even though CD1d-like proteins are not thought to exist
in amphibians, cartilaginous fish, or bony fish and even though
TCRs engageCD1d in a configuration that is completely different
from that of their engagement of conventional MHC. In every
case, recognition of MHC or CD1d was determined by at least
one amino acid in the motif.
Thus, a motif in CDR2 exists and functions similarly in some Vb
gene segments frommammals, amphibians, and bony and carti-
laginous fishes, species that last shared a common ancestor
more than 400 million years ago (Flajnik and Kasahara, 2010).
These experiments suggest that the predilection of at least
some TCR Vbs to interact with MHC was determined at least
400 million years ago, very early in vertebrate evolution. More-
over, it is likely that when CD1d and NKT cells evolved (Dascher,
2007), the immune system took advantage of Vbswith a preexist-
ing motif to produce TCRs that could react in a nonconventional
way with CD1d plus glycolipid ligands.
There are some exceptions to the idea that amino acid
sequences in the germline-encoded CDR loops of TCR-variable
regions confer the bias for MHC reactivity on T cells. For ex-
ample, for some TCRs, the non-germline-encoded CDR3 loops
dominate the interaction with their MHC-peptide ligand (Borg
et al., 2005; Tynan et al., 2005). Additionally, some TCRs bind
MHC in atypical orientations (Sethi et al., 2011), while other
TCRs that bind ligands other than MHC have been found (Ha-
nada et al., 2011). These examples suggest that the idea that
germline-encoded TCR regions have amino acids that promote
interaction with MHC might be incorrect. However, the ab TCR
repertoire is extraordinarily diverse and the highly selective pres-
sures of clonal expansion, thymic selection, or autoimmune re-
sponses may, in some cases, pick out cells expressing TCRs
that may not use conserved mechanisms for antigen specificity.
In spite of these exceptions, a large amount of crystallographic
and mutational data indicates that there is a CDR2 motif in
a group of jawed vertebrate Vbs that controls TCR interaction
with MHCI, MHCII, and CD1d (Borg et al., 2007; Dai et al.,
2008; Feng et al., 2007; Jerne, 1971; Lee et al., 2000; Manning
et al., 1998; Marrack et al., 2008; Maynard et al., 2005; Rudolph
et al., 2006; Scott-Browne et al., 2007, 2009).
Although the group of jawed vertebrate TCR Vb regions with
the tandemCDR2 tyrosines is somewhat small, there are several
Vb regions that contain similar amino acids at these positions.
Both tyrosine and phenylalanine are commonly found at these
positions in TCR Vbs. For example, Y46 (but not Y48) is found
in a family that is related to Vb8.2 including mouse Vb6 and
mouse Vb14 (Lefranc et al., 2009; Marrack et al., 2008). We
have observed previously that Vb6 CDR2 Y46 contributes
substantially to both specific MHCII-peptide recognition and532 Immunity 35, 526–535, October 28, 2011 ª2011 Elsevier Inc.enhances the efficiency of development of thymocytes express-
ing TCRs with this Vb (Scott-Browne et al., 2009). Similarly, in
crystal structures of mouse Vb7 (which also has the CDR2 Y48
amino acid) and Vb8.2 containing Va14i NKT TCRs bound to
aGalCer-CD1d, the Vb CDR2 Y48 side chain binds the CD1d
a1 a helix in a similar orientation and is required for antigen
recognition (Mallevaey et al., 2009; Pellicci et al., 2009).
Thus, although some of these CDR2 features are shared with
a larger group of Vbs, other Vbs in these species do not contain
these amino acids (Lefranc et al., 2009). It is possible that other
germline-encoded amino acids in these Vbs may have been
selected to promote binding to MHC or MHC-like proteins.
Indeed, TCRs that contain mouse Vb3, which does not share
this CDR2 motif, have been observed to bind to MHCII-peptide
complexes with a different motif and this interaction is shared
between different TCRs (Newell et al., 2011).
The evolution of TCR and their MHC ligands has long been
a mystery. It seems that neither could exist usefully without the
other and the two seem to have evolved almost simultaneously.
Moreover, if the idea that TCR variable regions have been
selected to engage MHC is right, how can this be achieved
when the TCR V region families are so large? How can natural
selection operate on individual members of the families? Of
course infectious disease is a powerful selective force, and indi-
vidual variable regions might each have a role to play in effective
responses to the many invading organisms that have plagued us
and our ancestors.
The data presented here support the coevolution point of view,
because, for at least some Vbs, the motif that predisposes
recognition of MHC appears to have existed in a common
ancestor of sharks and mammals, a common ancestor that
existed at least 400 million years ago. Evolution has found other
ways to solve the problem of clone-specific recognition of
antigen, such as the variable lymphocyte receptors expressed
in lampreys (Alder et al., 2005; Pancer and Cooper, 2006). In
the jawed vertebrates, T cell receptors and MHC, together
with the extremely variable antibody molecules, are firmly en-
trenched. The problem of how TCRs and MHC appeared within
a relatively short space of time remains unsolved.
The idea that TCR and MHC proteins have been evolutionarily
selected to bind one another (Jerne, 1971; Marrack et al., 2008)
may explain the high frequency of T cells that react with alloge-
neic MHC. Likewise, the observations presented here may also
account for the relatively high frequency of xenoreactive TCRs.
However, neither the data presented here nor elsewhere suggest
that TCR recognition of MHC is peptide independent. Rather, the
combined results indicate that TCR V regionmotifs bias TCRs for
generic recognition of MHC (Bevan, 1977a; Colf et al., 2007) and
that, usually, specific recognition of peptide, mostly by TCR
CDR3 regions, is needed to lift the affinity of the TCR interaction
with MHC-peptide interaction to trigger T cell activation (Colf
et al., 2007; Macdonald et al., 2009; Matzinger and Bevan,
1977; Morris et al., 2011; Rubtsova et al., 2009).EXPERIMENTAL PROCEDURES
TCR Vb Sequence Analysis
Sequences of the *01 allele of human, mouse, frog, and trout TCR Vb gene
segments (lacking the signal peptide) were downloaded from the IMGT
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Conserved Features that Control ab TCR Specificitydatabase (Lefranc et al., 2009). DNA sequences of opossum TCR Vb gene
segments were isolated from the genome sequence (MonDom5) with pub-
lished coordinates (Parra et al., 2008) and electronically translated in reading
frame 1. The region of the Vb surrounding CDR2 from human, mouse,
opossum, frog, and trout gene segments were isolated and searched for
a YxYxxxxxx motif with the 3of5 web application (Seiler et al., 2006).
Horned shark Vb sequences were searched manually for the CDR2 motif
from the list of published TCRb sequences (Hawke et al., 1996). We also
searched for Vb sequences with similarity to mouse Vb8.2 in the genome of
chicken (WASHUC2) and anole lizard (AnoCar2.0) with BLAST. Hits that
were in the same locus as TCRb constant gene segments were searched
manually for the CDR2 motif when aligned to mouse Vb8.2.
ab TCR Constructs
Plasmids encoding wild-type and mutant TCRa and TCRb chains for the
DO-11.10 TCR were described previously (Scott-Browne et al., 2009). DNA
fragments of frog TRBV2 (Lefranc et al., 2009) and shark Vb3-Hf73 (Hawke
et al., 1996) gene segments linked to mouse Vb8.2 signal peptide (plus Ala
substitutions of Y46, Y48, and E54) were synthesized by GenScript (Piscat-
away, NJ) based on published amino acid sequences. The trout TRBV8S2
gene segment was amplified by PCR from genomic DNA isolated from rainbow
trout fillet (Shamrock Foods, Commerce City, CO) and extended with overlap-
ping primers to encode the mouse Vb8.2 signal peptide. The sequence of the
Vb gene segment matched the published nucleotide sequence (AJ517978.1)
(Lefranc et al., 2009).
For retroviral expression, TCR constructs were cloned in MSCV-based
plasmids with natural mouse TCRa or b chain constant region plus an
IRES and GFP as a reporter, as described previously (Scott-Browne et al.,
2009). For expression in insect cells, TCRa and b chains were cloned in a
baculovirus transfer plasmid containing mouse TCRa and TCRb chain
constant regions, both truncated just before the transmembrane domain
and linked to complementary acidic or basic leucine zippers, as described
previously (Crawford et al., 2004; Kappler et al., 1994). The TCRa chain
constant region contained a single amino acid substitution N81D, to eliminate
a potential N-linked glycoslation site. The TCRb chain constant region con-
tained three amino acid substitutions (N5D, C70S, N115D) to eliminate two
potential N-linked glycosylation sites and to remove an unpaired cysteine.
The transmembrane region of the baculovirus gp64 protein was added to
the COOH-terminus of the TCRb chain to retain the protein on the surface
(Crawford et al., 2004).
Retroviral Packaging
Retroviral plasmids were cotransfected into Phoenix cells with pCLEco acces-
sory plasmid via Lipofectamine 2000 (Invitrogen, Carlsbad, CA), as described
previously (Scott-Browne et al., 2009).
Hybridomas
TCR constructs were expressed by retroviral transduction into a hybridoma
that lacks TCRa and TCRb (5KC-73.8.20) (White et al., 1993), as described
previously (Scott-Browne et al., 2009). After spin infection, expanded hybrid-
omas were sorted on a MoFlo XDP cell sorter (Beckman-Coulter) on the basis
of retroviral reporter and TCRb expression.
For all stimulations, 5 3 104 hybridoma cells were cultured overnight with
indicated stimuli. For OVA323-339 peptide stimulation, hybridomas were
cultured with 5 3 104 IAd-expressing A20.2J cells plus the indicated concen-
tration of peptide. For a-GalCer stimulation, hybridomas were cultured with
53 104 A20 cells expressing mouse CD1d (Brossay et al., 1998) plus the indi-
cated concentration of glycolipid. Hybridoma responses were measured by an
ELISA for IL-2, via standard protocols.
Insect Cells
SF9 insect cells were maintained as described previously (Kappler et al.,
1994). Genes encoding ab TCRs or MHCII molecules were introduced into
baculoviruses by cotransfection of the transfer plasmid plus linear Sapphire
baculovirus DNA (Orbigen, San Diego, CA) with calcium phosphate in SF9 cells
(Kappler et al., 1994). After 7–10 days, culture supernatant was collected and
expanded to high-titer stock by reinfection of SF9 cells, as described previ-
ously (Kappler et al., 1994).Tetramers
To generate IAd-OVA protein, the IAd a chain and the IAd b chain were cloned in
a baculovirus transfer vector, as described previously (Crawford et al., 1998;
Stadinski et al., 2010). The OVA peptide (GHAAHAEINEA) was linked to the
NH2 terminus of the IAd b chain with a flexible linker (GCGGTSGGGSGGS),
as described previously (Stadinski et al., 2010). The IAd a chain has an N72C
substitution and forms a disulfide bond with the cysteine in the linker between
the peptide and the IAd b chain (Stadinski et al., 2010).
IAd-OVA, IAd-CLIP, and IAb-3K tetramers were generated with phycoery-
thrin-labeled streptavidin plus biotinylated MHCII protein, as described pre-
viously (Crawford et al., 1998). Phycoerythrin-labeled mouse CD1d tetramers
loaded with PBS57 or without added antigen were provided by the NIH
tetramer facility.
Tetramer Staining
T cell hybridomas or SF9 insect cells (infected 3 days earlier with baculovirus)
were stainedwith 20 mgml1 phycoerythrin-labeledMHCII tetramer at 37C for
90 min in CD16/CD32 antibody producing hybridoma supernatant (clone
2.4G2), at which point allophycocyanin-labeled anti-TCRb (clone H57-597)
was added and stained for an additional 20 min at 25C. For CD1d tetramer
staining, T cell hybridomas were costained with phycoerythrin-labeled CD1d
tetramer and allophycocyanin-labeled anti-TCRb in 2.4G2 supernatant for
30 min at 25C.
Bone Marrow Chimeras
Bone marrow chimeras were generated as described previously (Scott-
Browne et al., 2009). In brief, bone marrow cells were harvested from
5-fluorouracil-treated TCRb/TCRd/ double-deficient mice and cultured
in medium containing IL-3, IL-6, and stem cell factor. Cells were retrovirally
infected on days 1, 2, and 3 of in vitro culture, and on day 4, 5.0 3 105
GFP-expressing cells were injected into irradiated Rag1/ mice (600 RAD).
Mice were analyzed at days 35–39 postreconstitution. Mice that reconstituted
poorly (those with less than 3.0 3 107 total thymocytes) were excluded from
the analysis. All experiments with mice were performed under protocols
approved by the Institutional Animal Care and Use Committee at National
Jewish Health.
Antibodies
Prior to staining, T cell hybridomas and ex vivo cells were incubated in super-
natant from an anti-CD16/CD32 producing hybridoma (clone 2.4G2). Cells
were stained under saturating conditions with antibodies to mouse TCRb
(clone H57-597), CD4 (clone GK1.5), CD8 (clone 53-6.7), CD5 (clone 53-7.3),
CD69 (clone H1.2F3), CD24 (clone M1/69), B220 (clone RA3-6B2), Va2 (clone
B20.1), and Va8.3 (clone B21.14) purchased from eBiosciences (San Diego,
CA), BD PharMingen (San Diego, CA), or generated in house.
Flow Cytometry
Cells were analyzed by flow cytometry on an LSR II (BD Biosciences, San
Diego, CA) and data were analyzed in FlowJo (Treestar, Ashland, OR).
Statistical Analysis
An unpaired, two-tailed Student’s t test was used to compare log10-
transformed data (GraphPad Prism, La Jolla, CA).
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